Inotiv
CLOSE ×
[Pharmaceutical development, Oncology, Travis Rothrock, bridging studies, Research models]

Best practices for bridging studies to generate data and validate a new strain

In this blog on bridging studies, we provide general best-practices relevant to oncology bridging studies, including basic study design considerations and insights that are the culmination of many...

[Oncology, Travis Rothrock, Research models]

Bridging studies - Why do researchers switch rodent strains?

Selecting the right model and rodent strain for your oncology studies can maximize the chances of success. However, there is an ever-increasing portfolio of available models and strains that may...

(TagWithUsageStats: { "associatedBlogIds" : [ ], "categoryId" : 0, "cdnPurgeEmbargoTime" : null, "contentIds" : [ ], "cosObjectType" : "TAG", "created" : 0, "deletedAt" : 0, "description" : "", "id" : 5436888851, "label" : "Travis Rothrock", "language" : null, "lastUsed" : 1574702838000, "livePosts" : 2, "name" : "Travis Rothrock", "portalId" : 212573, "publicUrl" : null, "publicUrls" : null, "slug" : "travis-rothrock", "status" : "active", "totalPosts" : null, "translatedFromId" : null, "translations" : { }, "updated" : 0 }) travis-rothrock

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now